NCT02651883 Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3 Status COMPLETED Phase NA
NCT02642471 Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010) Status ACTIVE_NOT_RECRUITING Phase NA
NCT02635360 Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer Status COMPLETED Phase PHASE2
NCT02629510 The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) Status UNKNOWN Phase PHASE4
NCT02628067 Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02624531 Prospective Study of Fertility-sparing Treatment Strategy in Patients With Early Cervical Cancer(SYSUGO-005/CSEM009) Status RECRUITING Phase NA
NCT02574442 Pilot Study In Vivo Confocal Microscopy Probe for Cervical Precancer Status TERMINATED Phase N/A
NCT02562508 A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls Status COMPLETED Phase PHASE3
NCT02558803 HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 Status COMPLETED Phase NA
NCT02558348 Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001) Status TERMINATED Phase PHASE1/PHASE2
NCT02554565 Innovation for Standard Identification of Insertional HPV Mutations and of Target Therapeutic Genes in Cervical Cancer: Towards Development of Personalized Biomarkers in Clinical Oncology (PAIR HPV) Status TERMINATED Phase NA
NCT02551887 HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts Status COMPLETED Phase NA
NCT02546752 Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine Status COMPLETED Phase EARLY_PHASE1
NCT02524756 Feasibility and Functional Outcome of Laparoscopic Nerve Sparing Radical Hysterectomy Status COMPLETED Phase NA
NCT02522585 p16 and Ki-67 Stainings and Natural Killer (NK) Cells in CIN-II Management Status COMPLETED Phase N/A